Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.

[1]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  M. Yoshiyama,et al.  Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study. , 2005, Journal of the American College of Cardiology.

[3]  P. Vardas,et al.  Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[4]  K. Fukuchi,et al.  Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  S. Hosoda,et al.  Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. , 2004, American heart journal.

[6]  J. Hatazawa,et al.  Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers. , 2004, Journal of the American College of Cardiology.

[7]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomized controlled trial☆ , 2003 .

[8]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[9]  O. Rimoldi,et al.  Myocardial blood flow in patients with hibernating myocardium. , 2003, Cardiovascular research.

[10]  S. Homma,et al.  Change in Coronary Flow Reserve on Transthoracic Doppler Echocardiography after a Single High-Fat Meal in Young Healthy Men , 2002, Annals of Internal Medicine.

[11]  D. Neglia,et al.  Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.

[12]  F. Eberli,et al.  Do beta-adrenergic blocking agents increase coronary flow reserve? , 2001, Journal of the American College of Cardiology.

[13]  J. Berlin,et al.  Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. , 2001, American heart journal.

[14]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[15]  M. Bristow.  β-Adrenergic Receptor Blockade in Chronic Heart Failure , 2000 .

[16]  H. Crijns,et al.  Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[17]  T Akasaka,et al.  Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. , 1998, Journal of the American College of Cardiology.

[18]  M. Phelps,et al.  Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  K. Adams,et al.  Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. , 1996, Circulation.

[20]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[21]  D. Neglia,et al.  Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. , 1995, Circulation.

[22]  P. Grayburn,et al.  Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. , 1995, Journal of the American College of Cardiology.

[23]  T. Inoue,et al.  Coronary flow reserve in patients with dilated cardiomyopathy. , 1993, American heart journal.

[24]  R D Fish,et al.  Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. , 1990, Circulation.

[25]  J. Parrillo,et al.  Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. , 1987, Journal of the American College of Cardiology.

[26]  W. Kübler,et al.  Coronary dilatory capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients. , 1983, The American journal of cardiology.